The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters

October 5, 2021 updated by: Öznur ERBAY DALLI, Ege University

The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters in Patients Receiving Ventilator Support in Intensive Care

The purpose of this study is to test the effect of a twice daily, 60-minute, nurse initiated, music listening intervention on patients followed in the ICU with MV support as compared to patients who receive care as usual and ear plugs.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

Delirium is an acute disorder of consciousness and cognitive function that occurs frequently in critical care settings. Many critically ill patients (e.g., up to 80% of patients) experience ICU delirium due to underlying medical or surgical health problems, recent surgical or other invasive procedures, medications, or various noxious stimuli (e.g., underlying psychological stressors, mechanical ventilation [MV], noise, light, patient care interactions, and drug-induced sleep disruption or deprivation). Delirium contributes to adverse outcomes such as increased mortality and morbidity, longer length of ICU stays, prolonged MV, costlier hospitalizations, and cognitive impairment after hospital discharge. The Society of Critical Care Medicine (SCMM) Clinical Practice Guidelines for the Prevention and Management of Pain, Agitation/Sedation, Delirium, Immobility, and Sleep Disruption in Adult Patients in the ICU (PADIS) recommend non-pharmacological interventions of preventing delirium and other symptoms. Music, which is one of the non-pharmacological applications, is one of the cognitive-behavioral treatment methods applied in the field of ICU as in many other fields. Music is easy method to apply and has no side effects and contributes to physical, psychological, emotional and spiritual healing. In the literature, it is seen that music intervention studies applied to patients followed in the ICU mostly focus on the effects on anxiety, pain, non-invasive ventilation tolerance, and stress response (heart rate, blood pressure, respiratory rate). The relationship between intensive care delirium and all these symptoms (pain, agitation, anxiety, stress response, etc.) and their interaction with each other have been clarified in the light of evidence-based guidelines and studies. Therefore, the aim of this study is to examine the effects of music applied to patients followed in the ICU with MV support on delirium, pain, need for sedation, anxiety and vital parameters.

Study Type

Interventional

Enrollment (Anticipated)

37

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İzmir, Turkey
        • Ege University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • ≥18 years,
  • Admitted to the ICU as of the start of the study and planned to be followed up in the ICU for at least 24 hours,
  • Needing invasive MV for at least 24 hours,
  • Pre-deliric score > 20%
  • At least one positive delirium according to CAM-ICU,
  • GCS score > 8,
  • RASS score ≥ -3,
  • Hemodynamically stable,
  • CPOT score ≥ 3

Exclusion Criteria:

  • Hearing or vision problems,
  • Diagnosed with psychiatric illness,
  • Diagnosed with dementia,
  • Having acute neurological injury,
  • Alcohol/drug poisoning
  • Hemodynamically unstable and treated with high-dose inotropic/vasopressor medication,
  • Pregnant,
  • Planned to be followed in ICU for less than 24 hours,
  • Does not need MV,
  • GCS score ≤ 8,
  • RASS score < -3,
  • Patients referred from another ICU

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Music group
"MusiCure®" compositions specially composed for the music group will be performed twice a day, between 10.00-11.00 a.m. and 14.00-15.00 p.m., for five days with headphones and a music player. Before the application, the sound level of the ICU environment will be measured with a decibel meter. At the 0th minute of the music application, at the 30th minute after starting the music, and at the 60th minute after the end of the music, the characteristics of delirium, pain, sedation level, anxiety and vital parameters will be recorded with data collection tools.
Music medicine
Active Comparator: Earplug group
In this group, patients will be given only earplugs. Before the application, the sound level of the ICU environment will be measured with a decibel meter. At the 0th minute of the intervention, at the 30th minute after starting intervention, and at the 60th minute after the end of the intervention, the characteristics of delirium, pain, sedation level, anxiety and vital parameters will be recorded with data collection tools.
Earplug with noise cancelling
No Intervention: Control group
The control group involves neither music intervention nor using earplug.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delirium
Time Frame: Date of study enrollment through 12 months.
The delirium event assessed twice daily by trained research nurse using the CAM-ICU. The diagnosis of delirium is based on the presence of two major criteria (i.e. acute or fluctuating onset plus lack of attention) and at least one of the minor criteria (disorganized thinking or altered consciousness level).
Date of study enrollment through 12 months.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Delirium severity
Time Frame: 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
In case of positive delirium, its severity assessed twice daily by trained research nurse using the CAM-ICU-7. CAM-ICU-7 is a seven point scale (0-7), derived from the RASS and the CAM-ICU.
2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Pain severity
Time Frame: 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Pain assessed by trained research nurse utilizing the Critical Care Pain Observation Tool (CPOT) a valid and reliable instrument in critically ill patients with and without delirium. The CPOT has 4 components: facial expression, body movements, muscle tension, and compliance with the ventilator for intubated patients or vocalization for extubated patients. Each component is scored from 0 to 2 with a possible total score ranging from 0 to 8. A CPOT ≥ 3 is indicative of significant pain.
2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Need of sedation
Time Frame: 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Sedation level assessed by trained research nurse using the Richmond Agitation-Sedation Scale (RASS). It is a ranking scale with 10-level (+4 "combative" to -5 "unarousable") used to measure the agitation or sedation level of a person.
2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Anxiety level
Time Frame: 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Anxiety level assessed by trained research nurse using Face Anxiety Scale. The scale is composed of five face types. The face type in the left-hand corner indicates an absence of anxiety, while anxiety increases towards the faces in the right-hand corner. When patient scores were three or above, their anxiety was determined to be medium to high.
2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Systolic/diastolic blood pressure
Time Frame: 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Changes in the systolic/diastolic blood pressure (mm/Hg). Blood pressure was recorded from monitor of patient.
2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Heart rate
Time Frame: 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Changes in the heart rate. Heart rate was measured as number of heartbeats in a per minute from monitor of patient.
2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Respiratory rate
Time Frame: 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Changes in the respiratory rate. Respiratory rate was measured as number of breaths in a per minute from monitor of patient.
2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Oxygen saturation
Time Frame: 2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization
Changes in the oxygen saturation. Saturation was recorded from monitor of patient.
2 times daily, before, midst and after each intervention for up to 5 days while in the ICU post randomization

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of ICU stay
Time Frame: During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)
The total days of ICU stay.
During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)
Duration of mechanical ventilation
Time Frame: During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)
The total days of mechanical ventilation.
During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)
Delirium duration
Time Frame: During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)
The delirium duration will be calculated when the patient is first considered to have delirium to the last time that patient is not supposed to have delirium based on CAM-ICU.
During ICU stay (from randomization until ICU discharge, or death, or 1 year follow-up)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 14, 2020

Primary Completion (Actual)

September 14, 2021

Study Completion (Anticipated)

October 1, 2021

Study Registration Dates

First Submitted

September 20, 2021

First Submitted That Met QC Criteria

October 5, 2021

First Posted (Actual)

October 19, 2021

Study Record Updates

Last Update Posted (Actual)

October 19, 2021

Last Update Submitted That Met QC Criteria

October 5, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Music

Subscribe